The increased expression of TLR4, TLR5, and TLR9 that we detected in patients with IBS is possibly in response to an increase in their endogenous ligands by disruption of the intestinal barrier and increased intestinal permeability, two suggested pathogenic mechanisms in IBS [29]. This evidence concerns the gene TLR5 and irritable bowel syndrome.